February 2010 Company Updates and Additions

3SBio Accuray Actelion Adjuvantix Advanced Cancer Therapeutics (ACT) ADVENTRX Pharmaceuticals Aegera Therapeutics Aequus BioPharma Agendia Agennix Akebia Therapeutics ALDA Pharmaceuticals Alizé Pharma Group Angiotech Pharmaceuticals Aprea Arrayit ART Advanced Research Technologies AutoGenomics AVEO Pharmaceuticals AVI BioPharma b3bio Bavarian Nordic BioMarin Pharmaceutical Cantab Biopharmaceuticals Cellceutix Cephalon ChemGenex Pharmaceuticals Chimerix Chroma Therapeutics Cleveland BioLabs (CBL) Cornerstone Pharmaceuticals Covance CureTech Cytopia Daiichi Sankyo Dainippon Sumitomo Pharma (DSP) Dako Deciphera Pharmaceuticals DiagnoCure Endocyte EntreMed EpiStem ERYtech Pharma FibroGen Five Prime Therapeutics (FivePrime) Fresenius Biotech Fuso Pharmaceutical Industries Galapagos Gamida Cell

Genmab Genoptix GlaxoSmithKline (GSK) GTC Biotherapeutics (GTC) Guided Therapeutics Helicos BioSciences Hiru HistoRx Human Genome Sciences (HGS) Infigo Diagnostics Kinex Pharmaceuticals Lead Therapeutics Life Technologies Ligon Discovery Liquidia Technologies MDS Millennium: The Takeda Oncology Company Misonix MolecularMD Myriad Genetics NeoGenomics NeurogesX Novelos Therapeutics Oncoscience OncoTherapy Science (OTS) ONYX Pharmaceuticals Polyphor Poniard Pharmaceuticals Pro-Pharmaceuticals PrognosDx Health Prolor Biotech Proteome Sciences Quidel R&D Biopharmaceuticals Rosetta Genomics sanofi-aventis Sareum Holdings Senesco Technologies Simcere Pharmaceutical Group TenX Biopharma Toshiba America Medical Systems (TAMS) Trion Pharma VaxGen Vermillion Vernalis Wellstat Biologics Wex Pharmaceuticals Xoma